Kết quả tìm kiếm - Sayed M.S. Hashemi

  • Đang hiển thị 1 - 18 kết quả của 18
Tinh chỉnh kết quả
  1. 1
    Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy

    Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy Bằng N.E. Verstegen, Frank J. Lagerwaard, Sayed M.S. Hashemi, Max Dahele, Ben J. Slotman, Suresh Senan

    Được phát hành 2015
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC

    Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC Bằng Ezgi B. Ulas, Sayed M.S. Hashemi, Ilias Houda, Adem Kaynak, Joris D. Veltman, Marieke F. Fransen, Teodora Radonic, Idris Bahce

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion–Positive Advanced NSCLC

    Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion–Positive Advanced NSCLC Bằng Bianca van Veggel, Adrianus J. de Langen, Sayed M.S. Hashemi, Kim Monkhorst, Daniëlle A.M. Heideman, Erik Thunnissen, Egbert F. Smit

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment

    Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment Bằng Adrianus J. de Langen, M. Jebbink, Sayed M.S. Hashemi, Justine L. Kuiper, J. de Bruin-Visser, Kim Monkhorst, Erik Thunnissen, Egbert F. Smit

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment

    Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment Bằng JG Kuiper, Sayed M.S. Hashemi, Erik Thunnissen, Peter J.F. Snijders, Katrien Grünberg, Elisabeth Bloemena, Daoud Sie, Pieter E. Postmus, Daniëlle A.M. Heideman, Egbert F. Smit

    Được phát hành 2016
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Systematic and combined endosonographic staging of lung cancer (SCORE study)

    Systematic and combined endosonographic staging of lung cancer (SCORE study) Bằng Laurence Crombag, Christophe Dooms, Jos A. Stigt, Kurt G. Tournoy, Olga C.J. Schuurbiers, Maarten K. Ninaber, Wieneke A. Buikhuisen, Sayed M.S. Hashemi, Peter I. Bonta, Daniël A. Korevaar, Jouke T. Annema

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14)

    A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14) Bằng R.C. Boshuizen, V.v.d. Noort, J.A. Burgers, Gerarda J.M. Herder, Sayed M.S. Hashemi, T. Jeroen N. Hiltermann, Peter W.A. Kunst, Jos A. Stigt, Michel M. van den Heuvel

    Được phát hành 2017
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with “Ultracentral” Non–Small Cell Lung Cancer

    Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with “Ultracentral” Non–Small Cell Lung Cancer Bằng H. Tekatli, N. Haasbeek, Max Dahele, Patricia de Haan, Wilko F.A.R. Verbakel, E. Bongers, Sayed M.S. Hashemi, Esther J. Nossent, F. Spoelstra, Adrianus J. de Langen, Ben J. Slotman, Suresh Senan

    Được phát hành 2016
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer

    Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer Bằng Bianca van Veggel, Juliana F. Vilacha Madeira R Santos, Sayed M.S. Hashemi, Marthe S. Paats, Kim Monkhorst, Daniëlle A.M. Heideman, Matthew R. Groves, Teodora Radonic, Egbert F. Smit, Ed Schuuring, Anthonie J. van der Wekken, Adrianus J. de Langen

    Được phát hành 2019
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis

    Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis Bằng David Planchard, Benjamin Besse, Harry J.M. Groen, Sayed M.S. Hashemi, Julien Mazières, Tae Min Kim, Élisabeth Quoix, Pierre‐Jean Souquet, Fabrice Barlési, Christina S. Baik, Liza C. Villaruz, Ronan J. Kelly, Shirong Zhang, Monique Tan, Eduard Gasal, Libero Santarpia, Bruce E. Johnson

    Được phát hành 2021
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors

    Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors Bằng Fariba Tohidinezhad, Dennis Bontempi, Zhen Zhang, Anne‐Marie C. Dingemans, Joachim G.J.V. Aerts, Gerben Bootsma, Johan Vansteenkiste, Sayed M.S. Hashemi, Egbert F. Smit, Hester A. Gietema, Hugo J.W.L. Aerts, André Dekker, Lizza Hendriks, Alberto Traverso, Dirk De Ruysscher

    Được phát hành 2023
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  12. 12
    Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC

    Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC Bằng M. Jebbink, Adrianus J. de Langen, Kim Monkhorst, Mirjam C. Boelens, Daan van den Broek, Vincent van der Noort, Cornedine J. de Gooijer, M. Mahn, Anthonie J. van der Wekken, Lizza Hendriks, Sayed M.S. Hashemi, Marthe S. Paats, Anne‐Marie C. Dingemans, Egbert F. Smit

    Được phát hành 2023
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  13. 13
    High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial

    High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial Bằng Fenneke Zwierenga, Bianca van Veggel, Lizza Hendriks, T. Jeroen N. Hiltermann, Birgitta I. Hiddinga, Lucie B.M. Hijmering Kappelle, Arja ter Elst, Sayed M.S. Hashemi, Anne‐Marie C. Dingemans, Cor van der Leest, Adrianus J. de Langen, Michel M. van den Heuvel, Anthonie J. van der Wekken

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  14. 14
    Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

    Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study Bằng Sayed M.S. Hashemi, Marieke F. Fransen, Anna-Larissa N. Niemeijer, Nicholas Taleb, Ilias Houda, Joris D. Veltman, Annemarie Becker‐Commissaris, Johannes M.A. Daniels, Laurence Crombag, Teodora Radonic, Gabrielle Jongeneel, S. Tarasevych, E. Looysen, Marjolein van Laren, M. Tiemessen, V. van Diepen, K. Maassen-van den Brink, Erik Thunnissen, Idris Bahce

    Được phát hành 2021
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  15. 15
    Real-world experience with capmatinib in <i>MET</i> exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

    Real-world experience with capmatinib in <i>MET</i> exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program Bằng Oliver Illini, Hannah Fabikan, Aurélie Swalduz, Anders Vikström, Dagmar Krenbek, Michael A. Schumacher, Elizabeth Dudnik, Michael Studnicka, R. Öhman, Robert Wurm, Luciano Wannesson, Nir Peled, Waleed Kian, Jair Bar, Sameh Daher, Alfredo Addeo, Ofer Rotem, Georg Pall, Alona Zer, Akram Saad, Tanja Čufer, Hadas Sorotsky, Sayed M.S. Hashemi, Katja Mohorčič, Ronen Stoff, Yulia Rovitsky, Shoshana Keren-Rosenberg, Thomas Winder, Christoph Weinlinger, Arschang Valipour, Maximilian J. Hochmair

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  16. 16
    Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

    Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program Bằng Oliver Illini, Maximilian J. Hochmair, Hannah Fabikan, Christoph Weinlinger, Amanda Tufman, Aurélie Swalduz, Kristina Lamberg, Sayed M.S. Hashemi, Florian Huemer, Anders Vikström, Martin Wermke, Gudrun Absenger, Alfredo Addeo, Shantanu Banerji, Antonio Calles, Stephen Clarke, Massimo Di Maïo, Alice Durand, M. Duruisseaux, Malinda Itchins, Okko-Sakari Kääränien, Florian Krenn, Eckart Laack, Adrianus J. de Langen, Katja Mohorčič, Georg Pall, Antonio Passaro, G. Prager, Achim Rittmeyer, J. Rothenstein, Michael A. Schumacher, Ewald Wöll, Arschang Valipour

    Được phát hành 2021
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  17. 17
    Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations

    Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations Bằng Bart Koopman, Harry J.M. Groen, Marjolijn J. L. Ligtenberg, Katrien Grünberg, Kim Monkhorst, Adrianus J. de Langen, Mirjam C. Boelens, Marthe S. Paats, Jan H. von der Thüsen, Winand N.M. Dinjens, Nienke Solleveld, Tom van Wezel, Hans Gelderblom, Lizza Hendriks, Ernst‐Jan M. Speel, Tom E. J. Theunissen, Leonie I. Kroeze, Niven Mehra, Berber Piet, Anthonie J. van der Wekken, Arja ter Elst, Wim Timens, Stefan M. Willems, Ruud W. J. Meijers, Wendy W.J. de Leng, Anne S. R. van Lindert, Teodora Radonic, Sayed M.S. Hashemi, Daniëlle A.M. Heideman, Ed Schuuring, Léon C.L.T. van Kempen

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  18. 18
    A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

    A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutat... Bằng Ross A. Soo, Ji‐Youn Han, Urania Dafni, Byoung Chul Cho, Chong Ming Yeo, Ernest Nadal, Enric Carcereny, Javier de Castro, María Ángeles Sala, Reyes Bernabé, Linda Coate, Mariano Provencio, Rosario García Campelo, Sinéad Cuffe, Sayed M.S. Hashemi, Martin Früh, Bartomeu Massutí, José García-Sánchez, Manuel Dómine, Margarita Majem, J.M. Sánchez-Torres, Christian Britschgi, Miklos Pless, Georgia Dimopoulou, Heidi Roschitzki‐Voser, Barbara Ruepp, Rafael Rosell, Rolf A. Stahel, Solange Peters, Rolf A. Stahel, Solange Peters, Ross A. Soo, Ji‐Youn Han, Martin Früh, Mariano Provencio, Linda Coate, Urania Dafni, Anita Hiltbrunner, Barbara Ruepp, Heidi Roschitzki‐Voser, Anita Hiltbrunner, Adriana Gasca-Ruchti, Nino Giacomelli, Rosita Kammler, Nesa Marti, Lionel Nobs, Mariana Pardo-Contreras, Rita Pfister, Anne‐Christine Piguet, Sabrina Ribeli-Hofmann, Virginia Rodriguez Martinez, Heidi Roschitzki‐Voser, Susanne Roux, Barbara Ruepp, Magdalena Sánchez-Hohl, Mirjam Schneider, Robin Schweri, Sandra Troesch, Isabel Zigomo, Urania Dafni, Zoi Tsourti, Panagiota Zygoura, Marie Kassapian, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, María Teresa Sariñena Fernandez, Eva Pereira, Carolina Simona, Lisa Tucker, Jillian Burnes, Aisling Barrett, Meghan McGrillen, Catherine Berset, Christine Biaggi, M. Reist, Priska Rentsch, Linda Coate, Sinéad Cuffe, Sayed M.S. Hashemi, Ernest Nadal, Enric Carcereny, Javier de Castro, María Ángeles Sala, Reyes Bernabé, Mariano Provencio, Rosario García Campelo, Bartomeu Massutí, José López García, Manuel Dómine, Margarita Majem, José Miguel Sánchez, Martin Früh, Christian Britschgi, Miklos Pless, Solange Peters, Ross A. Soo, Chong Ming Yeo, Ji‐Youn Han, Byoung Chul Cho

    Được phát hành 2021
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: